For patients seeking additional approaches to manage their Type 2 sugar, Mounjaro presents a significant advance. This drug, created by Lilly, works by targeting two receptors: GLP-1 and GIP, which play important roles in regulating sugar readings. Unlike many other therapies, Mounjaro demonstrates promise for significant physical loss in certai… Read More